|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/047 | |
| A61K 31/075 | |||
| A61K 31/336 | |||
| A61K 45/06 | |||
| A61K 38/12 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 2872161 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13809749.8 |
| Europos patento paraiškos padavimo data | 2013-06-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/047320 |
| Data | 2013-06-24 |
| (87) | Numeris | WO 2014/004376 |
| Data | 2014-01-03 |
| (30) | Numeris | Data | Šalis |
| 201261664279 P | 2012-06-26 | US | |
| 201361824672 P | 2013-05-17 | US |
| (72) |
BROWN, Dennis M., US
BACHA, Jeffrey A., CA
GARNER, William J., US
|
| (73) |
Del Mar Pharmaceuticals,
Suite 720 999 West Broadway, Vancouver, British Columbia V5Z 1K5,
CA
|
| (54) | DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS |
| DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS |